Press Release Source: Pharmacopeia, Inc.
Pharmacopeia Chairman and CEO to Present at SG Cowen's 24th Annual Health Care Conference On March 10, 2004
Thursday March 4, 3:54 pm ET
PRINCETON, N.J., March 4 /PRNewswire-FirstCall/ -- Pharmacopeia, Inc. (Nasdaq: ACCL - News) today announced that Dr. Joseph A. Mollica, Chairman, President and CEO, will present at the SG Cowen 24th Annual Health Care Conference at 9:00 a.m. on March 10, 2004 at The Boston Marriott Copley Place, 110 Huntington Avenue in Boston. A question and answer session will follow.
An audio webcast of the conference can be accessed at:
corporate-ir.net
Pharmacopeia (www.pharmacopeia.com) is a leader in enabling science and technology that accelerates and improves the drug discovery and chemical development processes. Pharmacopeia's Drug Discovery business integrates proprietary small molecule combinatorial chemistry, medicinal chemistry, high-throughput screening, in-vitro pharmacology, computational methods and informatics to discover and optimize lead compounds. Pharmacopeia's software subsidiary, Accelrys, develops and commercializes molecular modeling and simulation software for the life sciences and materials research markets, cheminformatics and decision support systems, and bioinformatics tools including gene sequence analysis. Pharmacopeia employs approximately 700 people and is headquartered in Princeton, New Jersey. |
